NASDAQ:RCKT

Rocket Pharmaceuticals Stock Insider Trading

etoro logo Buy RCKT
*Your capital is at risk
$3.11
-0.100 (-3.12%)
At Close: Jul 31, 2026

Rocket Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 73.02. In total, the insiders bought 7.75M and sold 517.25K RCKT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
73.02
Buy 7.75M shares
Sell 517.25K shares
58% Buy Activity
Strong Negative Correlation
Sell Signal Low Confidence
May 26, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 73.02.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 11, 2026
Buy
Stock Option (right to buy)
A-Award
Rizvi Syed Ali-aamir
Chief Medical Officer
Officer 93 037
Value: $301.4K
Feb 11, 2026
Buy
Common Stock
A-Award
Rizvi Syed Ali-aamir
Chief Medical Officer
Officer 61 963
Value: $200.8K
Feb 11, 2026
Buy
Stock Option (Right to Buy)
A-Award
Wilson Martin
General Counsel
Officer 468 187
Value: $1.52M
Feb 11, 2026
Buy
Stock Option (Right to Buy)
A-Award
Militello John
See Remarks
Officer 45 018
Value: $145.9K
Feb 11, 2026
Buy
Common Stock
A-Award
Militello John
See Remarks
Officer 29 982
Value: $97.1K
Feb 11, 2026
Buy
Common Stock
A-Award
Wilson Martin
General Counsel
Officer 311 813
Value: $1.01M
Feb 11, 2026
Buy
Common Stock
A-Award
Shah Gaurav
CEO
CEO / President 286 028
Value: $926.7K
Feb 11, 2026
Buy
Stock Option (Right to Buy)
A-Award
Shah Gaurav
CEO
CEO / President 870 648
Value: $2.82M
Jan 02, 2026
Buy
Common Stock
P-Purchase
Bjork Elisabeth
Director
Director 10 000
Value: $34.4K
Nov 18, 2025
Sell
Common Stock
S-Sale
Militello John
See Remarks
Officer 1 086
Value: $3K
Nov 18, 2025
Sell
Common Stock
S-Sale
Shah Gaurav
CEO
CEO / President 6 276
Value: $18.7K
Nov 18, 2025
Sell
Common Stock
S-Sale
Schwartz Jonathan David
See Remarks
Officer 2 545
Value: $8K
Nov 18, 2025
Sell
Common Stock
S-Sale
Wilson Martin
General Counsel
Officer 1 646
Value: $5K
Nov 03, 2025
Buy
Common Stock
A-Award
Wilson Martin
General Counsel
Officer 100 000
Value: $355.9K
Oct 14, 2025
Sell
Common Stock
S-Sale
Militello John
See Remarks
Officer 558
Value: $2K
Oct 14, 2025
Sell
Common Stock
S-Sale
Militello John
See Remarks
Officer 3 005
Value: $11.9K
Oct 14, 2025
Sell
Common Stock
S-Sale
Militello John
See Remarks
Officer 5 514
Value: $21.9K
Oct 14, 2025
Sell
Common Stock
S-Sale
Militello John
See Remarks
Officer 19 841
Value: $78.6K
Oct 06, 2025
Buy
Stock Option (right to buy)
A-Award
Rizvi Syed Ali-aamir
Chief Medical Officer
Officer 383 854
Value: $1.22M
Oct 06, 2025
Buy
Common Stock
A-Award
Rizvi Syed Ali-aamir
Chief Medical Officer
Officer 62 893
Value: $200.0K
Oct 06, 2025
Buy
Common Stock
A-Award
Rizvi Syed Ali-aamir
Chief Medical Officer
Officer 283 018
Value: $900.0K
Oct 06, 2025
Buy
Common Stock
A-Award
Rizvi Syed Ali-aamir
Chief Medical Officer
Officer 283 018
Value: $900.0K
Oct 06, 2025
Buy
Common Stock
A-Award
Rizvi Syed Ali-aamir
Chief Medical Officer
Officer 62 893
Value: $200.0K
Oct 06, 2025
Buy
Stock Option (right to buy)
A-Award
Rizvi Syed Ali-aamir
Chief Medical Officer
Officer 383 854
Value: $1.22M
Sep 24, 2025
Buy
Common Stock
A-Award
Fong Peter
Director
Director 30 000
Value: $99.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ROCKET PHARMACEUTICALS INC
Rocket Pharmaceuticals
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE